Autoimmune hemolytic anemia (AIHA) is a relatively uncommon disorder caused by
autoantibodies directed against self red blood cells. It can be idiopathic or secondary, and …

Anemia in Pregnancy: A Pragmatic Approach : Obstetrical & Gynecological Survey Anemia in
Pregnancy: A Pragmatic Approach : Obstetrical & Gynecological Survey Log in or Register …

Immune‐mediated hemolytic anemia (IMHA) is an important cause of morbidity and mortality
in dogs. IMHA also occurs in cats, although less commonly. IMHA is considered secondary …

The clinical outcome, response to treatment, and occurrence of acute complications were
retrospectively investigated in 308 primary autoimmune hemolytic anemia (AIHA) cases and …

The neonatal crystallizable fragment receptor (FcRn) functions as an intracellular protection
receptor for immunoglobulin G (IgG). Recently, several clinical studies have reported the …

Autoimmune hemolytic anemia (AIHA) is a rare and heterogeneous disease that affects 1 to
3/100 000 patients per year. AIHA caused by warm autoantibodies (w-AIHA), ie, antibodies …

Background: It is commonly accepted that antibody‐mediated removal of platelets
represents a major mechanism of platelet destruction in immune thrombocytopenic purpura …

Background Immune checkpoint inhibitors (CPI) are widely used in modern oncology and
have improved the prognosis of lung cancer, malignant melanoma, and other malignancies …

Autoimmune hemolytic anemia (AIHA) is an uncommon autoantibody-mediated immune
disorder that affects both children and adults. The diagnosis of AIHA relies mainly on the …

The treatment of both auto‐immune haemolytic anaemia (AIHA) and auto‐immune
thromobocytopenic purpura (AITP) remains unsatisfactory in those refractory to first‐line …